Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifeng Ding

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Cellular Signalling|September 17, 2023
Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCCYang Li, Muzhapaer Maimaiti, Bowen Yang, et al.
International Journal of Cancer|December 15, 2020
Oncometabolite L-2-hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinomaHuan Wang, Liya Wang, Qiming Zheng, et al.
European Journal of Medical Research|March 1, 2024
TR4 worsen urosepsis by regulating GSDMDHuan Wang, Shibin Zhu, Zhenwei Zhou, et al.
International Journal of Biological Sciences|January 3, 2023
Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising BiomarkersZeyi Lu, Yuanlei Chen, Wenqin Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2025
piR-RCC Suppresses Renal Cell Carcinoma Progression by Facilitating YBX-1 Cytoplasm LocalizationRuyue Wang, Fan Li, Yudong Lin, et al.
Molecular Therapy. Nucleic Acids|January 17, 2022
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitinationDanyang Shen, Lifeng Ding, Zeyi Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2025
Circular RNA-based therapy targeting metabolic vulnerability of fatty acid synthesis overcomes castration-resistant prostate cancerYudong Lin, Ruyue Wang, Fan Li, et al.
International Journal of Biological Sciences|April 20, 2026
PUS1 Drives Renal Cancer Progression by Preventing Formation of Endogenous Double-stranded RNAsZiwei Zhu, Zeyi Lu, Fan Li, et al.
Clinical and Translational Medicine|January 3, 2023
Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavageLifeng Ding, Qiming Zheng, Yudong Lin, et al.
Molecular Cancer|March 3, 2026
Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinomaYuanlei Chen, Zeyi Lu, Chao Qi, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Cellular Signalling|September 17, 2023
Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCCYang Li, Muzhapaer Maimaiti, Bowen Yang, et al.
International Journal of Cancer|December 15, 2020
Oncometabolite L-2-hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinomaHuan Wang, Liya Wang, Qiming Zheng, et al.
European Journal of Medical Research|March 1, 2024
TR4 worsen urosepsis by regulating GSDMDHuan Wang, Shibin Zhu, Zhenwei Zhou, et al.
International Journal of Biological Sciences|January 3, 2023
Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising BiomarkersZeyi Lu, Yuanlei Chen, Wenqin Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 24, 2025
piR-RCC Suppresses Renal Cell Carcinoma Progression by Facilitating YBX-1 Cytoplasm LocalizationRuyue Wang, Fan Li, Yudong Lin, et al.
Molecular Therapy. Nucleic Acids|January 17, 2022
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitinationDanyang Shen, Lifeng Ding, Zeyi Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2025
Circular RNA-based therapy targeting metabolic vulnerability of fatty acid synthesis overcomes castration-resistant prostate cancerYudong Lin, Ruyue Wang, Fan Li, et al.
International Journal of Biological Sciences|April 20, 2026
PUS1 Drives Renal Cancer Progression by Preventing Formation of Endogenous Double-stranded RNAsZiwei Zhu, Zeyi Lu, Fan Li, et al.
Clinical and Translational Medicine|January 3, 2023
Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavageLifeng Ding, Qiming Zheng, Yudong Lin, et al.
Molecular Cancer|March 3, 2026
Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinomaYuanlei Chen, Zeyi Lu, Chao Qi, et al.
Pageof 8